Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the role of inhaled corticosteroids to suppress nitric oxide gas exchange in
stable patients with moderate-to-severe COPD who are current non-smokers and not on oral
corticosteroids.
Details
Lead Sponsor:
Arthur F Gelb MD
Treatments:
Bronchodilator Agents Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Nitric Oxide Salmeterol Xinafoate Xhance